NEULAND LABS Fact Sheet, NEULAND LABS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS Fact Sheet    (NELB)


Going LIVE Today at 5pm: Our Special Event on India's Revival


Here is the latest financial fact sheet of NEULAND LABS. For more details, see the NEULAND LABS quarterly results and NEULAND LABS share price and chart. For a sector overview, read our pharmaceuticals sector report.

NEULAND LABS Price History

Price Rs 2,430.5
Mkt Cap Rs m 31,181
Vol '000 6.3
P/E X 58.0
P/CF X 65.7
EPS (TTM) Rs 41.9
% ch % 0.3
No. of shares m 12.83
% ch week % 5.8
% ch 1-mth % 19.8
% ch 12-mth % 513.6
52 week H/L Rs 2,543.1/350.0
(As on Apr 13, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

NEULAND LABS Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
NEULAND LABS EQUITY SHARE DATA
High Rs9241,5571,680828754 
Low Rs330678680431247 
Sales per share (Unadj.) Rs567.3643.9586.7519.7594.5 
Earnings per share (Unadj.) Rs30.452.113.412.812.6 
Diluted earnings per shareRs21.336.59.412.812.6 
Cash flow per share (Unadj.) Rs47.973.538.033.037.0 
Dividends per share (Unadj.) Rs2.00001.202.00 
Adj. dividends per shareRs1.400.000.001.202.00 
Dividend yield (eoy) %0.3000.20.4 
Book value per share (Unadj.) Rs207.6261.1275.0545.1553.4 
Adj. book value per shareRs145.5183.0192.7545.1553.4 
Shares outstanding (eoy) m8.998.998.9912.8312.83 
Bonus/Rights/Conversions  ---IS- 
Price / Sales ratio x1.11.72.01.20.8 
Avg P/E ratio x20.621.488.049.139.6 
P/CF ratio (eoy) x13.115.231.119.113.5 
Price / Book Value ratio x3.04.34.31.20.9 
Dividend payout %6.6009.415.8 
Avg Mkt Cap Rs m5,63410,04810,6088,0786,421 
No. of employees `0000.80.91.11.11.3 
Total wages/salary Rs m5579271,0301,1051,236 
Avg. sales/employee Rs Th6,430.96,389.54,655.05,906.35,949.4 
Avg. wages/employee Rs Th702.61,023.7909.0978.4963.8 
Avg. net profit/employee Rs Th344.6517.3106.4145.7126.4 
NEULAND LABS INCOME DATA
Net Sales Rs m5,1005,7895,2746,6687,627 
Other income Rs m1812453539 
Total revenues Rs m5,1175,8015,3196,7037,666 
Gross profit Rs m8091,0635045841,019 
Depreciation Rs m157192221259313 
Interest Rs m245211189157216 
Profit before tax Rs m425672139203529 
Minority Interest Rs m-20000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1492031939367 
Profit after tax Rs m273469121164162 
Gross profit margin %15.918.49.68.813.4 
Effective tax rate %35.130.213.419.169.4 
Net profit margin %5.48.12.32.52.1 
NEULAND LABS BALANCE SHEET DATA
Current assets Rs m3,1423,7504,4724,5355,152 
Current liabilities Rs m2,6802,8563,6693,2703,576 
Net working cap to sales %9.115.515.219.020.7 
Current ratio x1.21.31.21.41.4 
Inventory Days Days9185121105105 
Debtors Days Days851141349091 
Net fixed assets Rs m1,8662,0573,2143,6653,969 
Share capital Rs m909090129129 
"Free" reserves Rs m1,7772,2582,3826,8646,971 
Net worth Rs m1,8662,3482,4726,9937,100 
Long term debt Rs m4542981,035607774 
Total assets Rs m5,2418,85610,71411,30412,310 
Interest coverage x2.74.21.72.33.5 
Debt to equity ratio x0.20.10.40.10.1 
Sales to assets ratio x1.00.70.50.60.6 
Return on assets %9.97.72.92.83.1 
Return on equity %14.620.04.92.42.3 
Return on capital %28.833.49.44.79.5 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m3,8104,3563,9444,8355,187 
Fx outflow Rs m1,0739171,0021,6811,593 
Net fx Rs m2,7373,4392,9423,1543,594 
NEULAND LABS CASH FLOW
From Operations Rs m 448 387 113 699 573 
From Investments Rs m -199 -421 -1,163 -772 -487 
From Financial Activity Rs m -236 -1 1,048 120 -55 
Net Cashflow Rs m 14 -35 -2 47 33 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 36.3%
Foreign collaborators 0.0%
Indian inst/Mut Fund 63.7%
FIIs 0.0%
ADR/GDR 0.0%
Free float 63.7%
Shareholders 12,705
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Sanali Info Park, Road No 2, banjara Hills, Hyderabad 500034 Telangana
E-MAIL ir@neulandlabs.com WEB www.neulandlabs.com
TELEPHONE 040-30211600 FAX 040-30211602
SECTOR PHARMACEUTICALS GROUP
TR AGENT KFin Technologies Private Limited
YEAR OF INC: 1984 BSE CODE: 524558 FV (Rs): 10 DIV YIELD (%): 0.1

Read: NEULAND LABS 2019-20 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   GLENMARK PHARMA  ELDER PHARMA  AMAR REMEDIES  JUBILANT PHARMOVA   FDC  

Compare NEULAND LABS With:   GLENMARK PHARMA  ELDER PHARMA  AMAR REMEDIES  JUBILANT PHARMOVA   FDC  

Compare NEULAND LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  




Today's Market

India Top US Crude Oil Buyer in Q1CY21, Adani Ports Removed from S&P Index, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a strong note on Tuesday. Benchmark indices extended gains after the Indian government fast-tracked emergency approvals for foreign produced Covid-19 vaccines.

Views on news

NEULAND LABS Announces Quarterly Results (3QFY21); Net Profit Up 141.5% (Quarterly Result Update)

Feb 3, 2021 | Updated on Feb 3, 2021

For the quarter ended December 2020, NEULAND LABS has posted a net profit of Rs 267 m (up 141.5% YoY). Sales on the other hand came in at Rs 2 bn (up 20.5% YoY). Read on for a complete analysis of NEULAND LABS's quarterly results.

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On... (Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

Why the Market Fell Yesterday (Fast Profits Daily)

Apr 6, 2021

In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK NEULAND LABS

  • Track your investment in NEULAND LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NEULAND LABS

NEULAND LABS - ACTAVIS COMPARISON

COMPARE NEULAND LABS WITH

MARKET STATS